G protein selectivity is regulated by multiple intracellular regions of GPCRs

NeuroSignals

Volumn 12, Issue 1, 2003, Pages 1-12

  Wong, Stephen K F ^a  

^a PFIZER INC   (United States)

Author keywords

G protein; G protein coupled receptors; Selectivity

Indexed keywords

G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; CELL SURFACE RECEPTOR;

ALPHA HELIX; BIOAVAILABILITY; BIODIVERSITY; CELL MEMBRANE; CONFORMATION; MUTATION; PROTEIN ANALYSIS; PROTEIN DOMAIN; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; HUMAN; INTRACELLULAR FLUID; METABOLISM; PHYSIOLOGY;

ANIMALS; GTP-BINDING PROTEINS; HUMANS; INTRACELLULAR FLUID; RECEPTORS, CELL SURFACE;

EID: 0037762755     PISSN: 1424862X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068914     Document Type: Review

References (54)

1. Hopkins AL, Groom CR: The druggable genome. Nat Rev Drug Discov 2002;1:727-730.
2. Ross EM, Gilman AG: Biochemical properties of hormone-sensitive adenylate cyclase. Annu Rev Biochem 1980;49:533-564.
3. Cerione RA, Ross EM: Reconstitution of receptors and G proteins in phospholipid vesicles. Methods Enzymol 1991;195:329-342.
4. Probst WC, Snyder LA, Schuster DI, Brosius J, Sealfon SC: Sequence alignment of the G-protein-coupled receptor superfamily. DNA Cell Biol 1992;11:1-20.
5. Moller S, Vilo J, Croning MD: Prediction of the coupling specificity of G protein coupled receptors to their G proteins. Bioinformatics 2001;17(suppl 1):174-181.
6. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M, Miyano M: Crystal structure of rhodopsin: A G protein-coupled receptor. Science 2000;289:739-745.
7. Mixon MB, Lee E, Coleman DE, Berghuis AM, Gilman AG, Sprang SR: Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysis. Science 1995;270:954-960.
8. Higashijima T, Uzu S, Nakajima T, Ross EM: Mastoparan, a peptide toxin from wasp venom, mimics receptors by activating GTP-binding regulatory proteins (G proteins). J Biol Chem 1988;263:6491-6494.
9. o by mastoparan, related amphiphilic peptides, and hydrophobic amines; Mechanism and structural determinants of activity. J Biol Chem 1990;265:14176-14186.
10. Wakamatsu K, Okada A, Miyazawa T, Ohya M, Higashijima T: Membrane-bound conformation of mastoparan-X, a G-protein-activating peptide. Biochemistry 1992;31:5654-5660.
11. s alpha in a kinked helical conformation. Biochemistry 1997;36:3632-3639.
12. Blüml K, Mutschler E, Wess J: Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. Proc Natl Acad Sci USA 1994;91:7980-7984.
13. Okamoto T, Katada T, Murayama Y, Ui M, Ogata E, Nishimoto I: A simple structure encodes G protein-activating function of the IGF-II/mannose 6-phosphate receptor. Cell 1990;62:709-717.
14. Okamoto T, Takeda S, Murayama Y, Ogata E, Nishimoto I: Ligand-dependent G protein coupling function of amyloid transmembrane precursor. J Biol Chem 1995;270:4205-4208.
15. Murthy KS, Teng BQ, Zhou H, Jin JG, Grider JR, Makhlouf GM: G(i-1)/G(i-2)-dependent signaling by single-transmembrane natriuretic peptide clearance receptor. Am J Physiol Gastrointest Liver Physiol 2000;278:G974-G980.
16. o is a major growth cone protein subject to regulation by GAP-43. Nature 1990;344:836-841.
17. Parnell SC, Magenheimer BS, Maser RL, Rankin CA, Smine A, Okamoto T, Calvet JP: The polycystic kidney disease-1 protein, polycystin-1, binds and activates heterotrimeric G-proteins in vitro. Biochem Biophys Res Commun 1998;251:625-631.
18. Smine A, Xu X, Nishiyama K, Katada T, Gambetti P, Yadav SP, Wu X, Shi YC, Yasuhara S, Homburger V, Okamoto T: Regulation of brain G-protein go by Alzheimer's disease gene presenilin-1. J Biol Chem 1998;273:16281-16288.
19. Hedin KE, Duerson K, Clapham DE: Specificity of receptor-G protein interactions: Searching for the structure behind the signal. Cell Signal 1993;5:505-518.
20. Okamoto T, Nishimoto I: Detection of G protein-activator regions in M4 subtype muscarinic, cholinergic, and alpha 2-adrenergic receptors based upon characteristics in primary structure. J Biol Chem 1992;267:8342-8346.
21. Konig B, Arendt A, McDowell JH, Kahlert M, Hargrave PA, Hofmann KP: Three cytoplasmic loops of rhodopsin interact with transducin. Proc Natl Acad Sci USA 1989;86:6878-6882.
22. Cheung AH, Dixon RA, Hill WS, Sigal IS, Strader CD: Separation of the structural requirements for agonist-promoted activation and sequestration of the beta-adrenergic receptor. Mol Pharmacol 1990;37:775-779.
23. Chicchi GG, Graziano MP, Koch G, Hey P, Sullivan K, Vicario PP, Cascieri MA: Alterations in receptor activation and divalent cation activation of agonist binding by deletion of intracellular domains of the glucagon receptor. J Biol Chem 1997;272:7765-7769.
24. Alewijnse AE, Timmerman H, Jacobs EH, Smit MJ, Roovers E, Cotecchia S, Leurs R: The effect of mutations in the DRY motif on the constitutive activity and structural instability of the histamine H(2) receptor. Mol Pharmacol 2000;57:890-898.
25. Cao YJ, Gimpl G, Fahrenholz F: A mutation in the second intracellular loop of the pituitary adenylate cyclase activating polypeptide type I receptor confers constitutive receptor activation. FEBS Lett 2000;469:142-146.
26. Hwa J, Graham RM, Perez DM: Chimeras of alpha1-adrenergic receptor subtypes identify critical residues that modulate active state isomerization. J Biol Chem 1996;271:7956-7964.
27. 2+ cascades. Mol Endocrinol 1995;9:725-733.
28. Parnot C, Miserey-Lenkei S, Bardin S, Corvol P, Clauser E: Lessons from constitutively active mutants of G protein-coupled receptors. Trends Endocrinol Metab 2002;13:336.
29. Wess J, Bonner TI, Dorje F, Brann MR: Delineation of muscarinic receptor domains conferring selectivity of coupling to guanine nucleotide-binding proteins and second messengers. Mol Pharmac 1990;38:517-523.
30. Wong SK, Parker EM, Ross EM: Chimeric muscarinic cholinergic:beta- adrenergic receptors that activate Gs in response to muscarinic agonists. J Biol Chem 1990;265:6219-6224.
31. Wong SK, Ross EM: Chimeric muscarinic cholinergic:beta-adrenergic receptors that are functionally promiscuous among G proteins. J Biol Chem 1994;269:18968-18976.
32. Laugwitz KL, Allgeier A, Offermanns S, Spicher K, Van Sande J, Dumont JE, Schultz G: The human thyrotropin receptor: A heptahelical receptor capable of stimulating members of all four G protein families. Proc Natl Acad Sci USA 1996;93:116-120.
33. Hasegawa H, Negishi M, Ichikawa A: Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity. J Biol Chem 1996;271:1857-1860.
34. Eason MG, Liggett SB: Chimeric mutagenesis of putative G-protein coupling domains of the alpha2A-adrenergic receptor: Localization of two redundant and fully competent gi coupling domains. J Biol Chem 1996;271:12826-12832.
35. Verrall S, Ishii M, Chen M, Wang L, Tram T, Coughlin SR: The thrombin receptor second cytoplasmic loop confers coupling to Gq-like G proteins in chimeric receptors: Additional evidence for a common transmembrane signaling and G protein coupling mechanism in G protein-coupled receptors. J Biol Chem 1997;272:6898-6902.
36. Blin N, Yun J, Wess J: Mapping of single amino acid residues required for selective activation of Gq/11 by the m3 muscarinic acetylcholine receptor. J Biol Chem 1995;270:17741-17748.
37. Lai FP, Mody SM, Yung LY, Kam JY, Pang CS, Pang SF, Wong YH: Molecular determinants for the differential coupling of Galpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors. J Neurochem 2002;80:736-745.
38. Namba T, Sugimoto Y, Negishi M, Irie A, Ushikubi F, Kakizuka A, Ito S, Ichikawa A, Narumiya S: Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature 1993;365:166-170.
39. Milligan G, Marshall F, Rees S: G16 as a universal G protein adapter: Implications for agonist screening strategies. Trends Pharmacol Sci 1996;17:235-237.
40. Jordan BA, Devi LA: G-protein-coupled receptor heterodimerization modulates receptor function. Nature 1999;399:697-700.
41. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC: Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity. Science 2000;288:154-157.
42. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG, Lefkowitz RJ: Chimeric alpha 2-, beta 2-adrenergic receptors: Delineation of domains involved in effector coupling and ligand binding specificity. Science 1988;240:1310-1316.
43. Gomeza J, Joly C, Kuhn R, Knopfel T, Bockaert J, Pin JP: The second intracellular loop of metabotropic glutamate receptor 1 cooperates with the other intracellular domains to control coupling to G-proteins. J Biol Chem 1996;271:2199-2205.
44. 2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells. Mol Pharmacol 1995;48:344-351.
45. 2 dopamine/ m1 muscarinic receptor with D2 binding specificity mobilizes intracellular calcium in response to dopamine. FEBS Lett 1991;279:87-90.
46. Kostenis E: Is Galpha16 the optimal tool for fishing ligands of orphan G-protein-coupled receptors? Trends Pharmacol Sci 2001;22:560-564.
47. Olah ME: Identification of A2a adenosine receptor domains involved in selective coupling to Gs: Analysis of chimeric A1/A2a adenosine receptors. J Biol Chem 1997;272:337-344.
48. Liggett SB, Caron MG, Lefkowitz RJ, Hnatowich M: Coupling of a mutated form of the human beta 2-adrenergic receptor to Gi and Gs: Requirement for multiple cytoplasmic domains in the coupling process. J Biol Chem 1991;266:4816-4821.
49. Cotecchia S, Ostrowski J, Kjelsberg MA, Caron MG, Lefkowitz RJ: Discrete amino acid sequences of the alpha 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J Biol Chem 1992;267:1633-1639.
50. Carlson SA, Chatterjee TK, Fisher RA: The third intracellular domain of the platelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins: Studies using intracellular domain minigenes and receptor chimeras. J Biol Chem 1996;271:23146-23153.
51. Liu J, Wess J: Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family. J Biol Chem 1996;271:8772-8778.
52. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L: Differential signal transduction by five splice variants of the PACAP receptor. Nature 1993;365:170-175.
53. Gilchrist RL, Ryu KS, Ji I, Ji TH: The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. [Erratum in J Biol Chem 1996;271:26444.] J Biol Chem 1996;271:19283-19287.
54. Surprenant A, Horstman DA, Akbarali H, Limbird LE: A point mutation of the alpha 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science 1992;257:977-980.